19 de mayo de 2017, 00:24Geneva, May 19 (Prensa Latina) The World Health Organization (WHO) has today said that it is set to test the first global vaccine against Ebola in Africa, second outbreak of which is now affecting the Democratic Republic of Congo (DRC).
The Central African country has suffered seven previous outbreaks of Ebola since the virus was discovered there in 1976.
So far, he told reporters, no other deaths have been reported, but the World Health Organization thinks that there are at least 20 cases of the Zaire strain of Ebola, with two confirmed so far by laboratory testing.
DRC's latest Ebola outbreak has so far claimed three lives, with over twenty more lives on the line.
The MoH DRC and the WHO have indicated doing everything possible to contain the outbreak within the shortest possible time but "notwithstanding we need to be on the alert as a country and enhance our preparedness", a statement signed by the Director General, Ghana Health Service, Dr Anthony Nsiah-Asare, said.
"We can not underestimate the logistical and practical challenges associated with this response at a very remote part of the country", Salama said on the call. He said the vaccine must be kept at a temperature of -80 centigrade, a challenge in an area without wide-scale electrification. It is also an area that has been subject to insecurity and displacement.
"Risk at the regional level is moderate due to the proximity of worldwide borders and the recent influx of refugees from Central African Republic", the organization said, but it nonetheless described the global risk as low because the area is so remote.More news: India's absence from Belt and Road forum is likely to displease China
More news: Korea challenges South's new leader
More news: Trump praises virtues of being an 'outsider'
With the help of the United Nations, the first search teams, led by the DRC's Ministry of Health, flew into Likati on Wednesday. There are 18 other suspected cases.
At least 20 people are sick and three have been killed by the virus, World Health Organization officials said.
Protective gear has been dispatched to health workers and a mobile lab is being constructed and then deployed to the area. The region's telecommunications are also being updated.
During that epidemic, a vaccine made by Merck was successfully tested in hard-hit Guinea.
The trials there have been "promising" and the vaccines has proven to be efficient and safe so far, Salama told reporters.
The haemorrhagic fever has been most detrimental in West Africa, where it claimed more than 11,000 lives in 2014-15.